Medtronic

Founded in 1949, Medtronic, PLC is a global leader in the development of therapeutic and diagnostic medical devices. With its legal headquarters in Dublin, Ireland, and operational headquarters in Minneapolis, Minnesota, the company focuses on comprehensive cardiac and pain management solutions. Medtronic's core mission is to alleviate pain, restore health, and extend life through innovative medical technology. Their product portfolio includes devices for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, and treatments for both malignant and non-malignant pain and movement disorders.

Key figures associated with Medtronic include Geoff Martha, Chairman and CEO, and Karen L. Parkhill, CFO. The company is publicly traded on the NYSE under the ticker MDT and is a component of both the S&P 100 and S&P 500 indices. In 2023, Medtronic reported revenues of $31.23 billion and a net income of $3.76 billion. Celebrating its 75th anniversary, Medtronic has a storied history of innovation, from pioneering the first battery-powered pacemaker to leveraging AI for advanced cancer screening. Its impact on global healthcare is profound, continually pushing the boundaries of medical technology to improve patient outcomes worldwide.